Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Electrographic Flow Mapping VALidation in Patients With Persistent Atrial Fibrillation (EVAL AF)

NCT05093868 is registered in ClinicalTrials.gov with Corewell Health East as lead sponsor.

NCT NCT05093868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05093868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Electrographic Flow Mapping VALidation in Patients With Persistent Atrial Fibrillation (EVAL AF)
Lead sponsor
Corewell Health East
Phase
Not applicable
Overall status
Withdrawn
Start date
September 2, 2022
Completion date
September 2, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

longstanding persistent atrial fibrillation, persistent atrial fibrillation